Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | Gossamer Bio, Inc. GOSS | Invus Public Equities, L.P. | 6,258,880 2.800% | -8,072,642 (-56.33%) | Filing History |
| 2025-02-05 6:28 pm Purchase | 2024-12-31 | 13G | Gossamer Bio, Inc. GOSS | Octagon Capital Advisors LP | 19,576,054 8.600% | 19,576,054 (New Position) | Filing History |
| 2025-01-30 9:57 pm Sale | 2024-12-31 | 13G | Gossamer Bio, Inc. GOSS | The Vanguard Group | 10,034,149 4.420% | -1,601,485 (-13.76%) | Filing History |
| 2024-11-12 4:40 pm Sale | 2024-09-30 | 13G | Gossamer Bio, Inc. GOSS | Invus Public Equities, L.P. | 14,331,522 6.300% | -27,358 (-0.19%) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Gossamer Bio, Inc. GOSS | FMR LLC | 7,935,735 3.507% | -4,328,183 (-35.29%) | Filing History |
| 2024-08-02 6:30 pm Purchase | 2024-07-25 | 13G | Gossamer Bio, Inc. GOSS | Invus Public Equities, L.P. | 14,358,880 6.300% | 14,358,880 (New Position) | Filing History |
| 2024-02-14 4:40 pm Purchase | 2023-12-31 | 13G | Gossamer Bio, Inc. GOSS | HILLHOUSE INVESTMENT MANAGEMENT LTD. | 4,974,041 2.200% | 4,974,041 (New Position) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Gossamer Bio, Inc. GOSS | The Vanguard Group | 11,635,634 5.160% | 3,675,777 (+46.18%) | Filing History |
| 2024-02-09 5:35 pm Sale | 2023-07-24 | 13G | Gossamer Bio, Inc. GOSS | ARCH Venture Fund IX L.P. | 0 0.000% | -8,055,916 (Position Closed) | Filing History |
| 2024-02-09 09:03 am Purchase | 2024-02-08 | 13G | Gossamer Bio, Inc. GOSS | FMR LLC | 12,263,918 5.440% | 12,263,918 (New Position) | Filing History |
| 2024-01-11 4:30 pm Purchase | 2023-12-14 | 13G | Gossamer Bio, Inc. GOSS | Artal International S.C.A. | 13,108,880 5.800% | 13,108,880 (New Position) | Filing History |
| 2024-01-11 4:09 pm Sale | 2023-12-31 | 13G | Gossamer Bio, Inc. GOSS | Millennium Management LLC | 4,224,610 1.900% | -579,691 (-12.07%) | Filing History |
| 2023-07-28 3:46 pm Purchase | 2023-07-19 | 13D | Gossamer Bio, Inc. GOSS | Growth Equity Opportunities 18 VGE LLC | 18,793,076 8.200% | 18,793,076 (New Position) | Filing History |
| 2023-05-10 09:21 am Sale | 2023-04-30 | 13G | Gossamer Bio, Inc. GOSS | STATE STREET CORP STT | 1,319,485 1.390% | -26,524,500 (-95.26%) | Filing History |
| 2023-05-05 11:52 am Sale | 2023-04-30 | 13G | Gossamer Bio, Inc. GOSS | BlackRock Inc. BLK | 4,653,619 4.900% | -759,404 (-14.03%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Gossamer Bio, Inc. GOSS | HHLR ADVISORS LTD. | 4,974,041 5.300% | -2,446,933 (-32.97%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Gossamer Bio, Inc. GOSS | The Vanguard Group | 7,959,857 8.430% | 2,372,398 (+42.46%) | Filing History |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | Gossamer Bio, Inc. GOSS | BlackRock Inc. BLK | 5,413,023 5.700% | -16,663 (-0.31%) | Filing History |
| 2023-01-10 07:54 am Purchase | 2022-12-31 | 13G | Gossamer Bio, Inc. GOSS | STATE STREET CORP STT | 27,843,985 29.470% | 27,843,985 (New Position) | Filing History |
| 2023-01-04 4:21 pm Purchase | 2022-12-29 | 13G | Gossamer Bio, Inc. GOSS | Millennium Management LLC | 4,804,301 5.100% | 1,433,739 (+42.54%) | Filing History |